Genomic and Transcriptomic Alterations Associated with STAT3 Activation in Head and Neck Cancer.

about

Clinicopathologic implications of the miR-197/PD-L1 axis in oral squamous cell carcinoma Quantification of STAT3 and VEGF expression for molecular diagnosis of lymph node metastasis in breast cancer.

P2860

Q42371619-1AAAF2B5-B012-4C7F-A4FF-999D762BC918 Q47179344-852C0DB9-75FD-40E1-83CD-440650908CE3

P2860

Genomic and Transcriptomic Alterations Associated with STAT3 Activation in Head and Neck Cancer.

Item

http://www.wikidata.org/entity/Q36195093

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Genomic and Transcriptomic Alt ...... ation in Head and Neck Cancer.

@ast

Genomic and Transcriptomic Alt ...... ation in Head and Neck Cancer.

@en

type

Item

label

Genomic and Transcriptomic Alt ...... ation in Head and Neck Cancer.

@ast

Genomic and Transcriptomic Alt ...... ation in Head and Neck Cancer.

@en

prefLabel

Genomic and Transcriptomic Alt ...... ation in Head and Neck Cancer.

@ast

Genomic and Transcriptomic Alt ...... ation in Head and Neck Cancer.

@en

P1476

Genomic and Transcriptomic Alt ...... ation in Head and Neck Cancer.

@en

P2093

Daniel E Johnson

http://www.w3.org/2001/XMLSchema#string

Kelsey Pendleton

http://www.w3.org/2001/XMLSchema#string

Noah D Peyser

http://www.w3.org/2001/XMLSchema#string

Vivian W Y Lui

http://www.w3.org/2001/XMLSchema#string

William E Gooding

http://www.w3.org/2001/XMLSchema#string

P2860

Activation of signal transducer and activator of transcription 3 through a phosphomimetic serine 727 promotes prostate tumorigenesis independent of tyrosine 705 phosphorylation

Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas

Statistical significance for genomewide studies

Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study.

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial.

Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers

Frequent promoter hypermethylation of PTPRT increases STAT3 activation and sensitivity to STAT3 inhibition in head and neck cancer.

Loss-of-Function PTPRD Mutations Lead to Increased STAT3 Activation and Sensitivity to STAT3 Inhibition in Head and Neck Cancer

Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

P304

e0166185

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0166185

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jennifer Grandis

P577

2016-11-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27855189

http://www.w3.org/2001/XMLSchema#string

P921

transcriptome

P932

5113908

http://www.w3.org/2001/XMLSchema#string

Genomic and Transcriptomic Alterations Associated with STAT3 Activation in Head and Neck Cancer.

about

P2860

P2860

Genomic and Transcriptomic Alterations Associated with STAT3 Activation in Head and Neck Cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P932